Coral Laboratories appoints cost auditor for FY27
Coral Laboratories Limited has appointed M/s Aatish Dhattrak & Associates as its Cost Auditor for FY27, effective May 30, 2026. The Board approved the appointment following the Audit Committee's recommendation. The firm is unrelated to the company's directors.

*this image is generated using AI for illustrative purposes only.
Coral Laboratories Limited has appointed M/s Aatish Dhattrak & Associates as its Cost Auditor for the financial year 2026-2027. The appointment, effective from May 30, 2026, was approved by the Board of Directors based on the recommendation of the Audit Committee. This move ensures compliance with regulatory requirements governing cost audits for the upcoming fiscal year.
The decision was formalized during the Board meeting held on May 30, 2026. M/s Aatish Dhattrak & Associates, a partnership firm of Cost Accountants, brings extensive expertise in cost audit, accounts, audit, risk management, and project management. The firm holds a Firm Registration Number (FRN) of 101575.
Appointment Details
The company disclosed that there are no relationships between the newly appointed Cost Auditor and the directors of Coral Laboratories Limited. The appointment falls under the category of a new engagement rather than a change from a previous auditor.
Key Information
| Detail | Description |
|---|---|
| Name | M/s Aatish Dhattrak & Associates (FRN: 101575) |
| Designation | Cost Auditor |
| Reason for Change | Appointment |
| Date of Appointment | May 30, 2026 |
| Tenure | Financial Year 2026-2027 |
| Relationship with Directors | Not applicable |
Historical Stock Returns for Coral Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.52% | +4.29% | +20.96% | +5.38% | -18.74% | +7.23% |
What specific cost control measures does Coral Laboratories plan to implement with the new auditor's expertise?
How will the appointment impact the company's operational efficiency and profit margins in FY 2026-2027?
Are there any upcoming regulatory changes that might influence the scope of cost audits for Coral Laboratories?


































